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CASE REPORT
A 31-year-old woman presented with a two day
historyofsuddenonsetsevereconstantepigastric
pain associated with nausea and coffee-grounds
vomiting. She had a long history of heartburn
treated by her general practitioner with
intermittent omeprazole. There was nohistory of
melaena, peptic ulcer or gallstone disease.
However she had hadpulmonary embolismpost-
partum six years before andhadbeen on warfarin
for six months. Apart from intermittent
omeprazole, she was not on any regular
medication or oral contraceptive prior to
admission. On physical examination she was
tenderintheepigastric andperi-umbilicalregions
with some guarding. The remainder of the
examination was unremarkable. Haematological
and biochemical investigations were normal
except for an increased WCC of 28 x 109/L and
ESR of 50 mm/hr. Ultrasound scan of abdomen
wasunremarkable. Bariummealandgastroscopy
confirmed the presence of a large hiatus hernia
with linear reflux oesophagitis but no peptic
ulcer. She was re-commenced on omeprazole
regularly which settled her symptoms quickly
and she was discharged. She was readmitted two
days later as an emergency with relapse of her
symptoms. Repeat examination showed a mildly
distended abdomen with guarding and rebound
tenderness. Plainabdominalradiographs showed
mildlydilatedloopsofsmallbowel.Alaparotomy
was performed and a long segment of small
bowelinfarctioninvolvingthejejunumwasfound.
There was thrombus in the superior mesenteric
vein but the mesenteric arteries were patent. The
infarcted small bowel was resected to healthy
margins and intestinal continuity restored with
end-to-end anastomosis. Her post-operative
recovery was complicated by adult respiratory
distress syndrome requiring prolonged
endotracheal intubation and tracheostomy in the
intensivecareunit.Thrombophilic screenscarried
out in the first and second postoperative week
before commencement of warfarin therapy
TABLE
Classification ofthe causes ofmesenteric
venous thrombosis
Primary (30 per cent)
Antithrombin III deficiency
Protein C deficiency
Protein S deficiency
Platelet disorders
Myeloproliferative disorders
Splenectomy
Polycythaemia rubra vera
Pregnancy
Puerperium
Contraceptive pills
Secondary (60 per cent)
Intra-abdominal sepsis
Pancreatitis
Inflammatory intestinal disease
Trauma
Portal hypertension
Sclerotherapy of varices
Malignancy
Idiopathic (10 per cent)
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confirmed protein S deficiency (free protein S
level measured by ELISA was less than 30%)
withnormallevelsofantithrombinIIIandprotein
C. She was started on long-term therapy with
warfarin and she made a gradual recovery. She
remains well at six-month review. Screening of
her first-degree relatives shows no evidence of
familial thrombophilia. However her father had
died in his forties of vascular disease and had
mostprobablydeepvenousthrombosis, ashehad
suffered from venous ulceration of the lower
limbs.
DISCUSSION
Mesenteric venous thrombosis (MVT) is an
uncommonbutdistinctclinicalentity. Morecases
have been cited in the literature over the last two
decades. It is estimated to account for up to 20%
ofall cases ofintestinal infarction. Its incidence,
oratleastitsrecognition, appearstobeincreasing.1
Acute, subacute and chronic forms of MVT are
currently recognised.2 These forms may differ in
thesymptomstheyproduce,themethodsbywhich
they are diagnosed, and the treatment they may
require. Acute MVT has a more insidious and
unpredictable coursethan otherforms ofvisceral
ischaemic syndromes. It tends to affect younger
patients, and the mortality rate is as high as that
of the arterial counterpart. The most frequent
presentingsymptoms arenon-specific abdominal
pain, anorexia and diarrhoea. These symptoms
are presentforlongerthan48 hours in75% ofthe
cases in some series.3 Often the diagnosis was
delayed and over 60% of these cases underwent
a surgical procedure. Despite the increased
awareness ofthecondition, themortalityremains
high (more than 30%) and has not improved in
the last 20 years. The long term survival rate is
significantly worse in the acute form of MVT
than that of the chronic disease and there is also
ahigherrecurrencerate. Theprognosisisdirectly
related to the degree of intestinal infarction and
the underlying cause.
Bradbury et al classified MVT into primary,
secondary and idiopathic according to the cause
ofthe disease (Table4). Primary MVTs are due to
inherited or acquired thrombophilia such as
protein S deficiency, as in this case report.
Previous history of thromboembolism or family
history is usually present and it is important to
obtain adetailedpastmedical and family history.
Withincreasing sophistication ofhaematological
tests, more idiopathic cases will be identified as
primary MVT. Secondary MVTs are usually due
to intra-abdominal pathology such as sepsis or
inflammatory process. Despite the various
possiblecauses,MVTremainsasarareoccurrence.
Thediagnosis ofMVTremains achallenge tothe
clinicians. Symptoms and signs are usually non-
specific and the hallmark is pain that is out of
proportion to the physical findings. Despite the
advance of imaging techniques, pre-operative
diagnosis is made only in 10-15% of cases.4 A
highindexofsuspicionisparamountinrespectof
diagnosis and improved clinical outcome.
Ultrasonography and duplex scan may provide
information about the blood vessels concerned.
Contrast enhanced computed tomography (CT)
has proved to be useful in demonstrating venous
thrombus, ascites, intestinal wall thickening,
intestinaldilatationandpneumatosisintestinalis.5
It has established the diagnosis of MVT in up to
90% of cases in some series.6 Mesenteric
angiography is probably still the investigation of
choice but false negative studies are frequent
when thrombosis involves only segmental veins.
With improvement of imaging techniques,
contrast enhanced CT may soon replace
angiography as the first-line investigation. The
role ofMRI in MVT has not been fully explored
but its availability and expense will probably
limit its use.
There is no defined standard for treatment of
MVT, and various modalities have been
described.7'8 Treatment usually involves a
combinationofsurgicalprocedures, thrombolysis
and anticoagulation. In the presence of an acute
abdomen, laparotomy is usually necessary to
exclude ortoexcisenecrotic bowel. Second-look
operation may berequired ifviability ofbowel is
questionable. Successful conservative
management with efficacious anticoagulant
therapy and careful follow-up imaging has also
been reported.6 Whatever type of treatment is
used,promptdiagnosisandinstitutionoftreatment
are crucial to the improved outcome. The
possibility ofanunderlyinghypercoagulable state
should always be searched for as MVT could be
thefirstmanifestation ofthedisease. Ifthis is the
case, long term anticoagulation should be used
and the first- degree relatives should be screened
as they are at a high risk of developing
thromboembolism.
Protein S (PS), a vitamin-K dependent
glycoprotein, is a protein C cofactor which is
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necessary for the full anticoagulant effect of
activated protein C. In plasma, PS is partly free
and partly bound to C4b- binding protein. Only
freePS functions as acofactorforactivatedPCin
the inactivation of Factor Va and Factor VIIIa.
Many laboratories prefer to express free PS
antigen levels as apercentage of'normal' freePS
levels. This practice is acceptable but each
laboratory must establish its own normal ranges
for total and free PS antigen. In our laboratory,
the normal range for free PS antigen is 7-140%
(thefreePS antigenlevelwas27%inthisreported
case).
Protein S deficiency is an autosomal-dominant
inherited disorder of coagulation, either
homozygous (purpurafulminans atneonatal age)
or heterozygous. However acquired deficiencies
of PS have been described recently in several
conditions such as malignancy, pregnancy,
nephrotic syndrome and acute phase reactions.
The trueprevalence ofinherited PS deficiency is
unknown as not all the individuals with the
inherited PS deficiency will necessarily develop
thrombosis. Some studies have indicated a
frequency of 2-5% in patients with deep venous
thrombosis or pulmonary embolism. This is as
prevalent as protein C deficiency (5-8%) but less
common than antithrombin III deficiency (12-
15%).9 Patients with phenotypic PS deficiency
have a 50% chance of developing recurrent
thrombosis before age 45.10 However MVT is a
rare manifestation of this inherited disorder.
Frequently these thrombotic events are
accompanied by some precipitating factors such
as intake of oestrogen-containing oral
contraceptives andpregnancy. Inthepresentcase
however, no such triggering factors were
identified.
Theimportance ofwarfarin therapy inhereditary
thrombophilia cannot be over-emphasised.
However the duration of therapy remains
controversial. In patients with recurrent
thromboembolism, particularly affecting the
cerebralorsplanchniccirculation(asinthiscase),
long-term anticoagulant therapy is essential. In
asymptomatic patients orthosewithonly asingle
episode of thromboembolism, prophylactic
treatment to cover high risk events such as
pregnancy or surgery may be adequate.
With the history of recurrent thromboembolism
in a young patient, hereditary and acquired
thrombophilia must be considered and the
importance of early implementation of
anticoagulant therapy should not be
underestimated.
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